Evidence map›Paper›PMID 34321569›Full record

ArticleScientific reports2021

Positron emission tomography imaging with

Benjamin B Kasten, Hailey A Houson, Jennifer M Coleman, Jianmei W Leavenworth, James M Markert, Anna M Wu, Felix Salazar, Richard Tavaré, Adriana V F Massicano, G Yancey Gillespie and 3 more

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. [Theranostics · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Benjamin B Kasten *Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Hailey A Houson *Department of Radiology, University of Alabama at Birmingham, Volker Hall G082, 1670 University Boulevard, Birmingham, AL, 35294, USA.
Jennifer M ColemanDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Jianmei W LeavenworthDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
James M MarkertDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Anna M WuDepartment of Immunology and Theranostics, City of Hope, Duarte, CA, USA.
Felix SalazarDepartment of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Richard TavaréRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Adriana V F MassicanoDepartment of Radiology, University of Alabama at Birmingham, Volker Hall G082, 1670 University Boulevard, Birmingham, AL, 35294, USA.
G Yancey GillespieDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Suzanne E LapiDepartment of Radiology, University of Alabama at Birmingham, Volker Hall G082, 1670 University Boulevard, Birmingham, AL, 35294, USA.
Jason M WarramO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. mojack@uab.edu.
Anna G SoraceDepartment of Radiology, University of Alabama at Birmingham, Volker Hall G082, 1670 University Boulevard, Birmingham, AL, 35294, USA. asorace@uabmc.edu.
University of Alabama at Birmingham · USCity of Hope · USInstitute for Molecular Medicine · USRegeneron (United States) · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Biomarker Approaches to Individualizing Systemic Therapy for High Risk Prostate CancerR01CA240582 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FENG, FELIX YI-CHUNG, NGUYEN, PAUL L · 2020 to 2024
$3.4M
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMASP20CA151129 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GILLESPIE, G. YANCEY · 2011 to 2013
$2.3M
Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunityR01AI148711 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEAVENWORTH, JIANMEI WU · 2020 to 2024
$2.2M
Training Program in Brain Tumor BiologyT32NS048039 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BENVENISTE, ETTY N · 2007 to 2017
$2.0M
NCATS NIH HHS UL1 TR001417NCI NIH HHS P20 CA151129NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA240582NIAID NIH HHS R01 AI148711NINDS NIH HHS T32 NS048039
6 · The paper itself

Abstract

Determination of treatment response to immunotherapy in glioblastoma multiforme (GBM) is a process which can take months. Detection of CD8

Indexed as

AnimalsCD8 AntigensCD8-Positive T-LymphocytesCell Line, TumorDisease Models, AnimalGliomaHumansMiceOncolytic VirotherapyRadioisotopesSimplexvirusTomography, X-Ray ComputedZirconiumCD8 AntigensRadioisotopesZirconiumZirconium-89

Identifiers

PMID34321569
PMCPMC8319402
OpenAlexW3185662999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.